The efficacy of a new Alzheimer’s drug is under scrutiny after it was granted accelerated approval by the Food and Drug Administration this month. Leqembi, a treatment developed by Japanese biotech company Eisai and American biotech Biogen, has demonstrated more success in trial studies than any Alzheimer’s drug before. A recent study published in the...
